首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

2112455

抽吸裝置：市場洞察、競爭格局及市場預測 - 2034 年

Aspiration Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

出版日期: 2026年08月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

概述：

預計到 2025 年，抽吸裝置市值將達到 41.5 億美元，到 2034 年將達到 98 億美元。這一成長是由全球缺血性中風和靜脈血栓栓塞症發病率的增加、微創血管和神經血管手術的日益普及以及智慧型電腦輔助吸引技術的不斷創新所推動的。
全球吸痰設備市場預計在 2026 年至 2034 年的預測期內將以 10.0% 的複合年成長率成長。
按產品類型分類，預計吸痰導管細分市場將在吸痰設備市場中主導，到 2025 年將佔 38% 的市場佔有率。
從操作方式來看，預計到 2025 年，真空吸力裝置將引領吸力裝置市場，佔 46% 的市佔率。
按應用領域分類，預計到 2025 年，血管抽吸領域將以 33% 的市佔率引領抽吸裝置市場。
按最終用戶分類，預計到 2025 年，醫院領域將主導吸痰設備市場，佔 61% 的市場。
預計到 2025 年，北美將以 44% 的銷售額引領全球吸痰設備市場，在全球區域市場佔有率中佔最高地位。

抽吸裝置是一類廣泛的醫療設備，包括吸引導管、吸引泵、吸引套管、吸引針及相關耗材，用於利用真空或機械吸引的方式清除體內的血栓、血塊、液體、空氣、組織碎片或其他不需要的物質。這些裝置廣泛應用於各種臨床場景，例如急性缺血性腦中風、肺動脈栓塞和深層靜脈栓塞症形成的血管血栓切除術，以及普通外科手術中用於清除液體和煙霧的吸引，甚至在重症監護、急診醫學和居家醫療中用於清除呼吸道分泌物和粘液的吸引。市場依產品類型可分為吸引導管、吸引幫浦、吸引套管和吸引針；依作用機制可分為真空吸引、機械吸引和手動吸引；依應用領域可分為血管和神經血管吸引，其次是外科手術和呼吸道吸引；依最終使用者分類，醫院為主要市場。受中風和血栓性栓塞症發生率上升、微創介入手術加速發展以及從智慧吸泵到大口徑扭矩響應導管等產品不斷創新的推動，吸力裝置已成為血管外科、介入神經病學、介入放射學、急診醫學和重症監護中不可或缺的工具。

吸力裝置市場的主要市場促進因素

全球缺血性中風和靜脈血栓栓塞症負擔日益加重，推動了抽吸血栓切除術的需求。 Stryker 於 2025 年 2 月完成對 Inari Medical 的 49 億美元收購，進一步擴大了該公司周邊血管和靜脈血栓栓塞症相關產品系列的產品組合，從而支持了這一趨勢。
隨著微創血管、神經血管和外科手術的普及，醫生越來越傾向於採用抽吸法清除血栓和組織，而不是採用開顱手術等其他方法。
由於持續的產品創新，包括 Penumbra 的「THUNDERBOLT」電腦輔助真空血栓切除術 (CAVT) 平台（於 2026 年 6 月獲得 FDA 批准）和 Inari Medical 的「Artix 血栓切除系統」（於 2025 年 3 月推出），該手術的效率得到了提高，其在臨床實踐中的應用擴大。
法規核准和適應症擴展正在加速，AngioDynamics 的「AlphaVac F1885 系統」於 2024 年 4 月獲批用於肺動脈栓塞，Imperative Care 的「Zoom 7X 吸痰導管」和「Symphony 血栓切除系統」於 2025 年，這些都證明了這一點，這些都證明了這一點。
隨著全球呼吸系統疾病發生率上升，需要重症監護和急診治療的住院人數增加，對外科和呼吸/氣道吸痰設備的需求仍然強勁。
醫院和門診手術中心的基礎設施擴建，特別是中風專科中心和心臟導管檢查室的發展，導致需要使用吸痰裝置的手術數量增加。
透過積極的併購和投資活動，例如 Stryker 收購 Inari Medical，以及 Penumbra、Boston Scientific 和 Medtronic 不斷擴大產能，創新正在整合，全球企業發展也在擴大。
疾病負擔加重、微創手術的廣泛應用以及持續的產品創新預計將推動市場在 2034 年前保持強勁和持續的成長。

推動吸力裝置市場成長的因素

市場促進因素

缺血性中風和靜脈血栓栓塞症負擔加重

抽吸裝置市場最強勁的促進因素是全球急性缺血性腦中風、深層靜脈栓塞症和肺動脈栓塞負擔的日益加重，這推動了對吸引血栓切除術的需求。卒中仍然是全球主要的死亡和長期殘疾原因，而僅在美國，每年就有數十萬名患者受到靜脈血栓栓塞症的影響。透過將吸引導管與真空幫浦結合使用，醫生可以直接從阻塞的血管中抽吸血栓，並透過微創的導管介入方法恢復血流。商業性和策略發展勢頭強勁，以至於在2025年2月，史賽克公司以49億美元完成了對Inari Medical公司的收購，以鞏固其在快速成長的周邊血管和靜脈血栓栓塞症領域的地位，並將Inari的吸引和機械血栓切除系統FlowTriever和ClotTriever整合到史賽克的神經血管產品組合中。隨著中風專科中心的擴張和血栓切除術標準的擴大，預計到 2034 年，神經血管和血管血栓切除術中使用的抽吸裝置的需求將穩步成長。

微創手術的普及速度正在加速。

微創血管、神經血管和外科手術的結構性轉變是該市場的主要成長動力。基於抽吸的血栓和組織清除技術正日益受到介入放射學、開放性手術外科、介入神經病學和普通外科的醫生和醫院的青睞，因為它能夠減輕手術期間的身體負擔，縮短恢復時間，並降低併發症發生率，優於傳統開放手術。抽吸導管和幫浦可實現直接、持續或智慧的真空血栓捕獲，而抽吸套管和針頭則用於清除手術室內的體液、組織和煙霧。隨著微創技術在各個專科領域不斷取代傳統開放性手術，需要使用抽吸裝置的手術範圍也不斷擴大。

市場限制因素

儘管發展勢頭強勁，但抽吸裝置市場仍面臨諸多限制因素。先進的抽吸血栓切除系統相關的高昂手術和器械成本可能會限制其在對成本敏感且資源有限的醫療機構中的應用。不同地區對新適應症和新技術的保險報銷仍有差異。血管和神經血管介入治療方面對專業醫生的訓練需求限制了其應用速度，尤其是在大型中風和血管中心以外的地區。主要市場複雜且不斷變化的監管要求延長了新器械的核准和適應症擴展流程。器械相關併發症，例如血管損傷和血栓清除不完全，需要持續累積臨床證據才能將其納入更廣泛的指南。製造商之間日益激烈的競爭和價格壓力正在擠壓成熟產品類型（例如手動抽吸裝置和標準手術套管）的利潤空間。儘管疾病負擔加重、微創治療普及和創新等強勁的潛在促進因素推動著市場發展，但成本、培訓、監管和競爭等障礙共同作用，減緩了市場成長速度。

吸痰裝置市場：市場促進因素
- 缺血性中風和靜脈血栓栓塞症負擔加重
- 微創手術的普及速度正在加速。
- 持續的技術創新
- 呼吸系統疾病負擔日益加重，對重症監護的需求不斷成長。
吸痰裝置市場：限制因素與挑戰
- 高昂的治療和設備成本
- 保險報銷和醫生培訓方面的差異。
- 監管和競爭環境的複雜性
吸痰裝置市場：市場機遇
- 電腦輔助真空血栓切除術的廣泛應用
- 新興市場和門診服務的拓展

第4章：人工智慧、地緣政治、貿易與經濟趨勢

第5章：監理分析

美國
歐洲
日本
中國

第6章：波特五力分析

第7章：吸痰設備市場：評估

依產品類型
- 吸痰管
- 吸泵浦
- 吸管
- 吸針
- 其他
透過機制
- 真空吸力裝置
- 機械吸力
- 手動吸
用途別
- 血管抽吸裝置
- 神經血管穿刺
- 手術吸力
- 呼吸道/氣道吸痰
最終用戶
- 醫院
- 專科診所
- 門診手術中心
按地區
- 北美洲
- 歐洲
- 亞太地區
- 世界其他地區

第8章：吸痰裝置市場：競爭格局

市場集中度與結構
競爭定位與市場佔有率分析（加值服務）

第9章：吸痰設備市場：新創企業資金籌措與投資趨勢

第10章吸痰設備市場：公司概況與產品概況

Penumbra, Inc.
Stryker
Medtronic
BD
Teleflex
Medela
Laerdal Medical
Boston Scientific
Inari Medical
IAngioDynamics

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章免責聲明與聯絡方式

簡介目錄圖表

Product Code: DIMDCL0971

Aspiration Devices Market Summary

Overview:

The Aspiration Devices market is estimated at USD 4.15 billion in 2025 and is projected to reach USD 9.80 billion by 2034. Growth is anchored in the rising global burden of ischemic stroke and venous thromboembolism, the expanding adoption of minimally invasive vascular and neurovascular procedures, and continued innovation in intelligent, computer-assisted aspiration technology.
The global Aspiration Devices market is growing at a CAGR of 10.0% during the forecast period from 2026 to 2034.
By product type, the aspiration catheters segment dominated the Aspiration Devices market with a 38% share in 2025.
By mechanism, the vacuum-based aspiration segment dominated the Aspiration Devices market with a 46% share in 2025.
By application, the vascular aspiration segment dominated the Aspiration Devices market with a 33% share in 2025.
By end-user, the hospitals segment dominated the Aspiration Devices market with a 61% share in 2025.
North America dominated the global Aspiration Devices market revenue with a 44% share in 2025, representing the highest regional market share globally.

Aspiration devices are a broad class of medical instruments, comprising aspiration catheters, aspiration pumps, aspiration cannulas, aspiration needles, and related consumables, used to remove clot, thrombus, fluid, air, tissue debris, or other unwanted material from the body through applied vacuum or mechanical suction. These devices span a wide range of clinical settings, from neurovascular thrombectomy for acute ischemic stroke and vascular thrombectomy for pulmonary embolism and deep vein thrombosis, to general surgical aspiration for fluid and smoke evacuation, and respiratory or airway aspiration for secretion and mucus clearance in critical care, emergency medicine, and home settings. The market is organized by product type across aspiration catheters, aspiration pumps, aspiration cannulas, and aspiration needles; by mechanism, spanning vacuum-based aspiration, mechanical suction, and manual aspiration; by application, led by vascular and neurovascular aspiration alongside surgical and respiratory or airway aspiration; and by end-user, dominated by hospitals. Driven by the rising incidence of stroke and thromboembolic disease, the accelerating shift toward minimally invasive interventional procedures, and continuous product innovation from intelligent aspiration pumps to large-lumen, torque-responsive catheters, aspiration devices have become foundational tools across vascular surgery, interventional neurology, interventional radiology, emergency medicine, and critical care.

Aspiration Devices Market Key Growth Drivers

The rising global burden of ischemic stroke and venous thromboembolism is driving demand for aspiration thrombectomy, underscored by Stryker's USD 4.9 billion acquisition of Inari Medical completed in February 2025 to expand its peripheral vascular and venous thromboembolism portfolio.
The accelerating shift toward minimally invasive vascular, neurovascular, and surgical procedures is expanding physician preference for aspiration-based clot and tissue removal over open surgical alternatives.
Continuous product innovation, including Penumbra's FDA-cleared THUNDERBOLT computer-assisted vacuum thrombectomy (CAVT) platform in June 2026 and Inari Medical's Artix Thrombectomy System launched in March 2025, is improving procedural efficiency and expanding clinical adoption.
Accelerating regulatory clearances and label expansions, including AngioDynamics' AlphaVac F1885 System clearance for pulmonary embolism in April 2024 and Imperative Care's Zoom 7X aspiration catheter and Symphony Thrombectomy System clearances in 2025, are broadening the addressable patient population.
The rising global incidence of respiratory disorders and growth of critical care and emergency medicine admissions are sustaining steady demand for surgical and respiratory or airway aspiration devices.
Growing hospital and ambulatory surgical center infrastructure, particularly the expansion of dedicated stroke centers and cardiac catheterization labs, is increasing procedure volumes that require aspiration devices.
Heavy M&A and investment activity, including Stryker's acquisition of Inari Medical and continued capacity expansion by Penumbra, Boston Scientific, and Medtronic, is consolidating innovation and expanding global commercial reach.
The convergence of rising disease burden, minimally invasive procedure adoption, and sustained product innovation is expected to support strong, durable growth in the market through 2034.

Key Companies in Aspiration Devices Market

The competitive landscape is led by the following active manufacturers:

Penumbra, Inc.
Stryker
Medtronic
BD
Teleflex
Medela
Laerdal Medical
Boston Scientific
Inari Medical
AngioDynamics

Factors Contributing to the Growth of the Aspiration Devices Market

Market Drivers

Rising Burden of Ischemic Stroke and Venous Thromboembolism

The most powerful driver of the Aspiration Devices market is the rising global burden of acute ischemic stroke, deep vein thrombosis, and pulmonary embolism, which is expanding demand for aspiration-based thrombectomy. Stroke remains a leading cause of death and long-term disability worldwide, and venous thromboembolism affects hundreds of thousands of patients annually in the United States alone. Aspiration catheters combined with vacuum pumps allow physicians to directly suction clot from occluded vessels, restoring blood flow with a minimally invasive, catheter-based approach. Commercial and strategic momentum is substantial: Stryker completed its USD 4.9 billion acquisition of Inari Medical in February 2025 to strengthen its position in the fast-growing peripheral vascular and venous thromboembolism segment, bringing Inari's FlowTriever and ClotTriever aspiration and mechanical thrombectomy systems into Stryker's neurovascular portfolio. As dedicated stroke centers expand and thrombectomy eligibility criteria broaden, demand for aspiration devices used in neurovascular and vascular thrombectomy is set to grow steadily through 2034.

Accelerating Shift toward Minimally Invasive Procedures

A structural shift toward minimally invasive vascular, neurovascular, and surgical procedures is a central growth engine for the market. Aspiration-based clot and tissue removal offers reduced procedural trauma, shorter recovery times, and lower complication rates relative to open surgical alternatives, driving physician and hospital preference across interventional radiology, vascular surgery, interventional neurology, and general surgery. Aspiration catheters and pumps enable direct, continuous, or intelligent vacuum-based clot capture, while aspiration cannulas and needles support fluid, tissue, and smoke evacuation in surgical settings. As minimally invasive techniques continue to displace open procedures across specialties, the addressable base of procedures requiring aspiration devices continues to widen.

Market Restraints

Despite strong momentum, the Aspiration Devices market faces material constraints. High procedural and device costs associated with advanced aspiration thrombectomy systems can limit adoption in cost-sensitive and lower-resource healthcare settings, while reimbursement for newer indications and technologies remains uneven across geographies. The need for specialized physician training in vascular and neurovascular intervention constrains the pace of adoption, particularly outside major stroke and vascular centers. Complex and evolving regulatory requirements across major markets lengthen approval timelines for new devices and label expansions. Device-related complications, including vessel injury and incomplete clot removal, require ongoing clinical evidence generation to support broader guideline inclusion. Intense competitive and pricing pressure among a growing number of manufacturers is compressing margins in mature product categories such as manual aspiration devices and standard surgical cannulas. Together, these cost, training, regulatory, and competitive barriers temper the pace of growth, even as the underlying drivers of disease burden, minimally invasive adoption, and innovation remain firmly intact.

Aspiration Devices Market Segment Analysis

The aspiration devices market by product type (aspiration catheters, aspiration pumps, aspiration cannulas, aspiration needles, and others), mechanism (vacuum-based aspiration, mechanical suction, manual aspiration, and others), application (vascular aspiration, neurovascular aspiration, surgical aspiration, respiratory/airway aspiration, and others), end-user (hospitals, specialty clinics, ambulatory surgical centers, and others), and geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Aspiration Catheters.

The aspiration catheters segment accounted for 38% of the Aspiration Devices market in 2025. Aspiration catheters are the leading product type because they are the primary interface for vacuum-based clot and thrombus removal in neurovascular and vascular thrombectomy, and because continuous innovation in large-lumen, torque-responsive catheter design is expanding their clinical role. Products such as Penumbra's Indigo Aspiration System catheters and Inari Medical's FlowTriever and ClotTriever catheters, now part of Stryker's portfolio, illustrate the segment's technological depth and commercial scale. Aspiration pumps, the essential vacuum source paired with these catheters, represent the second-largest category and are growing quickly alongside catheter adoption, while aspiration cannulas and needles remain foundational to general surgical and respiratory aspiration. While aspiration pumps are growing fastest as intelligent, computer-assisted vacuum technology gains adoption, the breadth of clinical indications and the recurring, single-use nature of catheter consumption secure the aspiration catheters segment's leadership across the forecast period.

By Mechanism

Dominant Subsegment: Vacuum-Based Aspiration.

The vacuum-based aspiration segment accounted for 46% of the Aspiration Devices market in 2025. Vacuum-based aspiration is the leading mechanism because it underpins the majority of modern thrombectomy and clot-removal procedures, offering continuous or intelligently modulated suction that improves clot capture while minimizing vessel trauma. Penumbra's FDA-cleared THUNDERBOLT platform, which introduces computer-assisted vacuum thrombectomy technology powered by the Penumbra Engine, exemplifies the segment's technological trajectory toward automated, sensor-guided vacuum control. Mechanical suction devices remain widely used in general surgical and respiratory applications, while manual aspiration continues to serve cost-sensitive and point-of-care settings, including emergency and home-use scenarios. As vacuum-based systems increasingly incorporate intelligent clot-detection and modulation technology, the segment is expected to extend its leadership across the forecast period.

Aspiration Devices Market Region Analysis

Dominant Region: North America

North America accounted for 44% of the global Aspiration Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a mature stroke and vascular care ecosystem, a dense network of comprehensive stroke centers and cardiac catheterization labs, clear FDA regulatory pathways, and the direct presence of leading manufacturers including Penumbra, Stryker, Boston Scientific, BD, Teleflex, and AngioDynamics. North America hosts the largest concentration of thrombectomy-capable stroke centers and venous thromboembolism treatment programs, and sponsors benefit from strong reimbursement frameworks and rapid access to newly cleared technology. Stryker's completion of its acquisition of Inari Medical in February 2025 reinforced the region's commercial depth in peripheral vascular aspiration, while Penumbra's June 2026 FDA clearance for THUNDERBOLT extended domestic neurovascular innovation. Strong reimbursement, regulatory clarity, and manufacturer concentration anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Aspiration Devices market. The region's elevated CAGR is driven by rising stroke and cardiovascular disease incidence, rapid expansion of hospital and stroke-center infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding its network of stroke-ready hospitals and interventional radiology capacity, Japan is broadening reimbursement for advanced thrombectomy technology, and India is scaling minimally invasive vascular and surgical procedure volumes as tertiary care infrastructure expands. Government healthcare investment, an aging population, and growing awareness of early stroke and thromboembolism intervention are accelerating adoption, while regional distributors and manufacturers scale access to global aspiration device platforms. The combination of rising disease burden, infrastructure build-out, and improving procedural access positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 44% of the global Aspiration Devices market revenue in 2025. The United States dominates on the strength of its stroke and vascular care infrastructure, FDA regulatory clarity, and the direct presence of leading manufacturers, while continued product launches, including Penumbra's THUNDERBOLT and Inari Medical's Artix Thrombectomy System, and Stryker's expanded peripheral vascular portfolio following the Inari acquisition, reinforce the region's leadership.

Europe

Europe is a large and advanced regional market, supported by established stroke-care and vascular intervention networks, CE-marking regulatory pathways, and growing adoption of intelligent aspiration technology across Germany, France, the United Kingdom, Italy, and Spain. Expanding comprehensive stroke center coverage and rising venous thromboembolism awareness continue to support steady demand for both neurovascular and vascular aspiration devices across the region.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising stroke and cardiovascular disease incidence, rapid hospital and stroke-center infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. Expanding interventional radiology and neurology capacity, alongside improving reimbursement for advanced thrombectomy technology, is accelerating regional adoption of aspiration devices.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and critical-care infrastructure, rising demand for minimally invasive vascular and surgical intervention, and efforts to build stroke-ready treatment networks are gradually broadening access, while distributor partnerships with global manufacturers support the build-out of regional procedural capacity.

Aspiration Devices Market Competitive Landscape

The Aspiration Devices market is classified as Moderately Concentrated. A group of large, diversified medical technology companies with broad vascular, neurovascular, and surgical device portfolios, including Stryker, Medtronic, Boston Scientific, BD, and Teleflex, secures large hospital contracts and anchors the top tier, while specialized and fast-scaling providers such as Penumbra, AngioDynamics, Medela, and Laerdal Medical compete through focused clinical evidence, device innovation, and category leadership in specific applications such as neurovascular thrombectomy, respiratory aspiration, and emergency airway management, increasing competition across the fastest-growing application segments.

The competitive landscape can be evaluated across the following dimensions:

Market concentration: Moderately concentrated, with large diversified medtech players leading and a focused field of specialized aspiration-technology innovators.
Leading players: Stryker, Medtronic, Boston Scientific, BD, and Teleflex anchor the top tier through broad vascular, neurovascular, and surgical device portfolios.
Geographic reach: Leaders operate global, multi-country commercial networks; Penumbra supports healthcare providers, hospitals, and clinics in more than 100 countries.
Product portfolio strength: Top players offer end-to-end aspiration catheters, pumps, cannulas, and needles spanning neurovascular, vascular, surgical, and respiratory applications.
Technology access: Intelligent, computer-assisted vacuum thrombectomy platforms, such as Penumbra's THUNDERBOLT CAVT system, and integrated aspiration-and-mechanical thrombectomy systems, such as Inari Medical's Artix, are decisive competitive advantages.
Strategic partnerships and M&A: Active consolidation, most notably Stryker's USD 4.9 billion acquisition of Inari Medical completed in February 2025, is reshaping competitive positioning in vascular and venous thromboembolism aspiration.
Regulatory track record: A strong history of FDA 510(k) clearances and label expansions, exemplified by AngioDynamics' AlphaVac F1885 clearance and Imperative Care's Zoom 7X and Symphony clearances, is a key differentiator.
Manufacturing capabilities: Large-lumen catheter engineering, intelligent aspiration control electronics, and sterile single-use device manufacturing at scale are key competitive moats.
Innovation focus: Computer-assisted vacuum thrombectomy, integrated aspiration-mechanical thrombectomy platforms, expanded indications for pulmonary embolism and deep vein thrombosis, and portable, intelligent aspiration pumps for surgical and respiratory use.

Aspiration Devices Market Recent Developmental Activities

In June 2026, Penumbra, Inc., received U.S. FDA clearance for THUNDERBOLT, expanding its computer-assisted vacuum thrombectomy (CAVT) technology to address acute ischemic stroke.

In March 2025, Inari Medical, Inc. (part of Stryker), launched the Artix Thrombectomy System, an integrated platform combining aspiration and mechanical thrombectomy for peripheral arterial disease.

Aspiration Devices Market Segmentation

Aspiration Devices Market by Product Type

Aspiration Catheters
Aspiration Pumps
Aspiration Cannulas
Aspiration Needles
Others

Aspiration Devices Market by Mechanism

Vacuum-Based Aspiration
Mechanical Suction
Manual Aspiration
Others

Aspiration Devices Market by Application

Vascular Aspiration
Neurovascular Aspiration
Surgical Aspiration
Respiratory/Airway Aspiration
Others

Aspiration Devices Market by End-User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

Aspiration Devices Market by Geography

North America Aspiration Devices Market
United States Aspiration Devices Market Size in USD million (2023-2034)
Canada Aspiration Devices Market Size in USD million (2023-2034)
Mexico Aspiration Devices Market Size in USD million (2023-2034)
Europe Aspiration Devices Market
Germany Aspiration Devices Market Size in USD million (2023-2034)
United Kingdom Aspiration Devices Market Size in USD million (2023-2034)
France Aspiration Devices Market Size in USD million (2023-2034)
Italy Aspiration Devices Market Size in USD million (2023-2034)
Spain Aspiration Devices Market Size in USD million (2023-2034)
Rest of Europe Aspiration Devices Market Size in USD million (2023-2034)
Asia-Pacific Aspiration Devices Market
China Aspiration Devices Market Size in USD million (2023-2034)
Japan Aspiration Devices Market Size in USD million (2023-2034)
India Aspiration Devices Market Size in USD million (2023-2034)
Australia Aspiration Devices Market Size in USD million (2023-2034)
South Korea Aspiration Devices Market Size in USD million (2023-2034)
Rest of Asia-Pacific Aspiration Devices Market Size in USD million (2023-2034)
Rest of the World (RoW) Aspiration Devices Market
Middle East Aspiration Devices Market Size in USD million (2023-2034)
Africa Aspiration Devices Market Size in USD million (2023-2034)
South America Aspiration Devices Market Size in USD million (2023-2034)

Key Takeaways from the Aspiration Devices Market Report Study

Market size analysis for the current aspiration devices market size (2025), and market forecast for 9 years (2026 to 2034).
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
Key companies dominating the global aspiration devices market.
Various opportunities available for competitors in the aspiration devices market space.
What are the top-performing segments in 2025? How will these segments perform in 2034?
Which are the top-performing regions and countries in the current aspiration devices market scenario?
Which are the regions and countries where companies should concentrate their opportunities for aspiration devices market growth in the future?

Target audience who can benefit from this aspiration devices market report study

Aspiration Devices product providers
Research organizations and consulting companies
Neurodegenerative disease therapeutics-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in aspiration devices
Various end-users who want to know more about the aspiration devices market and the latest technological developments in the aspiration devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the aspiration devices market?

The aspiration devices market is projected to expand at a CAGR of 10.0% during the forecast period from 2026-2034.

Q2. What is the market size of the aspiration devices market?

The aspiration devices market is estimated at USD 4.15 billion in 2025 and is projected to reach USD 9.80 billion by 2034.

Q3. Which region dominates the aspiration devices market?

North America dominated the Aspiration Devices market with a 44% share of global revenue in 2025, supported by a mature stroke and vascular care ecosystem, a dense network of comprehensive stroke centers, FDA regulatory clarity, and the direct presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the aspiration devices market?

The principal drivers are the rising global burden of ischemic stroke and venous thromboembolism, underscored by Stryker's USD 4.9 billion acquisition of Inari Medical in February 2025; the accelerating shift toward minimally invasive vascular, neurovascular, and surgical procedures; continuous technological innovation, including Penumbra's FDA-cleared THUNDERBOLT computer-assisted vacuum thrombectomy platform; accelerating regulatory clearances and label expansions; and rising respiratory disease burden and critical care demand.

Q5. Who are the major players in the Aspiration Devices market?

The major players include Penumbra, Inc., Stryker, Medtronic, BD, Teleflex, Medela, Laerdal Medical, Boston Scientific, Inari Medical, and AngioDynamics, among other active providers profiled in the Competitive Landscape section, along with Imperative Care and other specialized manufacturers. Stryker, Medtronic, Boston Scientific, BD, and Teleflex lead through broad vascular, neurovascular, and surgical device portfolios.

1. Aspiration Devices Market Report Introduction

1.1 Scope of the Study
1.2 Market Segmentation
1.3 Market Assumptions

2. Aspiration Devices Market Executive Summary

2.1 Market at a Glance

3. Aspiration Devices Market Key Factors Analysis

3.1 Aspiration Devices Market Drivers
- 3.1.1 Rising Burden of Ischemic Stroke and Venous Thromboembolism
- 3.1.2 Accelerating Shift toward Minimally Invasive Procedures
- 3.1.3 Continuous Technological Innovation
- 3.1.4 Rising Respiratory Disease Burden and Critical Care Demand
3.2 Aspiration Devices Market Restraints and Challenges
- 3.2.1 High Procedural and Device Costs
- 3.2.2 Reimbursement and Physician Training Gaps
- 3.2.3 Regulatory and Competitive Complexity
3.3 Aspiration Devices Market Opportunities
- 3.3.1 Computer-Assisted Vacuum Thrombectomy Scale-Up
- 3.3.2 Emerging-Market and Ambulatory Care Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

5.1 United States
5.2 Europe
5.3 Japan
5.4 China

6. Aspiration Devices Market Porter's Five Forces Analysis

6.1 Bargaining Power of Suppliers
6.2 Bargaining Power of Buyers
6.3 Threat of New Entrants
6.4 Threat of Substitutes
6.5 Competitive Rivalry

7. Aspiration Devices Market Assessment

7.1 By Product Type
- 7.1.1 Aspiration Catheters
- 7.1.2 Aspiration Pumps
- 7.1.3 Aspiration Cannulas
- 7.1.4 Aspiration Needles
- 7.1.5 Others
7.2 By Mechanism
- 7.2.1 Vacuum-Based Aspiration
- 7.2.2 Mechanical Suction
- 7.2.3 Manual Aspiration
- 7.2.4 Others
7.3 By Application
- 7.3.1 Vascular Aspiration
- 7.3.2 Neurovascular Aspiration
- 7.3.3 Surgical Aspiration
- 7.3.4 Respiratory/Airway Aspiration
- 7.3.5 Others
7.4 By End-Users
- 7.4.1 Hospitals
- 7.4.2 Specialty Clinics
- 7.4.3 Ambulatory Surgical Centers
- 7.4.4 Others
7.5 By Geography
- 7.5.1 North America
  - 7.5.1.1 United States Market Size in USD million (2023-2034)
  - 7.5.1.2 Canada Market Size in USD million (2023-2034)
  - 7.5.1.3 Mexico Market Size in USD million (2023-2034)
- 7.5.2 Europe
  - 7.5.2.1 Germany Market Size in USD million (2023-2034)
  - 7.5.2.2 United Kingdom Market Size in USD million (2023-2034)
  - 7.5.2.3 France Market Size in USD million (2023-2034)
  - 7.5.2.4 Italy Market Size in USD million (2023-2034)
  - 7.5.2.5 Spain Market Size in USD million (2023-2034)
  - 7.5.2.6 Rest of Europe Market Size in USD million (2023-2034)
- 7.5.3 Asia-Pacific
  - 7.5.3.1 China Market Size in USD million (2023-2034)
  - 7.5.3.2 Japan Market Size in USD million (2023-2034)
  - 7.5.3.3 India Market Size in USD million (2023-2034)
  - 7.5.3.4 Australia Market Size in USD million (2023-2034)
  - 7.5.3.5 South Korea Market Size in USD million (2023-2034)
  - 7.5.3.6 Rest of Asia-Pacific Market Size in USD million (2023-2034)
- 7.5.4 Rest of World
  - 7.5.4.1 Middle East Market Size in USD million (2023-2034)
  - 7.5.4.2 Africa Market Size in USD million (2023-2034)
  - 7.5.4.3 South America Market Size in USD million (2023-2034)

8. Aspiration Devices Market Competitive Landscape

8.1 Market Concentration and Structure
8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Aspiration Devices Market Startup Funding and Investment Trends

10. Aspiration Devices Market Company and Product Profiles

10.1 Penumbra, Inc.
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
10.2 Stryker
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
10.3 Medtronic
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
10.4 BD
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
10.5 Teleflex
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
10.6 Medela
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
10.7 Laerdal Medical
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
10.8 Boston Scientific
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
10.9 Inari Medical
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy

10. AngioDynamics

10.10.1 Company Overview
10.10.2 Company Snapshot
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.